Evidence map›Paper›PMID 27905924›Full record

ReviewMicrobial cell factories2016

Current knowledge and perspectives of Paenibacillus: a review.

Elliot Nicholas Grady, Jacqueline MacDonald, Linda Liu, Alex Richman, Ze-Chun Yuan

Open access · goldAbstract readReview
In one paragraph

Review in Microbial cell factories, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 417 papers.

0numbers the graph read from it
0cells of the map it votes in
417citing papers in PubMed
59.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

417 citing papers in PubMed, 948 citations in OpenAlex.

  1. Article
  2. Biocontrol of Fungal Pathogens of Winter Oilseed Rape (Molecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Retrospective Analysis ofMicroorganisms · 2026
    Article
  8. Article
  9. Pine-Extracted Volatile Oils Suppress Root Rot inPlants (Basel, Switzerland) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

357 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elliot Nicholas GradyLondon Research and Development Centre, Agriculture & Agri-Food Canada, 1391 Sandford Street, London, ON, N5V 4T3, Canada.
Jacqueline MacDonaldDepartment of Microbiology & Immunology, Schulich School of Medicine & Dentistry, University of Western Ontario, Dental Science Building Rm. 3014, London, ON, N6A 5C1, Canada.
Linda LiuLondon Research and Development Centre, Agriculture & Agri-Food Canada, 1391 Sandford Street, London, ON, N5V 4T3, Canada.
Alex RichmanLondon Research and Development Centre, Agriculture & Agri-Food Canada, 1391 Sandford Street, London, ON, N5V 4T3, Canada.
Ze-Chun YuanLondon Research and Development Centre, Agriculture & Agri-Food Canada, 1391 Sandford Street, London, ON, N5V 4T3, Canada. zyuan27@uwo.ca.
Agriculture and Agri-Food Canada · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isolated from a wide range of sources, the genus Paenibacillus comprises bacterial species relevant to humans, animals, plants, and the environment. Many Paenibacillus species can promote crop growth directly via biological nitrogen fixation, phosphate solubilization, production of the phytohormone indole-3-acetic acid (IAA), and release of siderophores that enable iron acquisition. They can also offer protection against insect herbivores and phytopathogens, including bacteria, fungi, nematodes, and viruses. This is accomplished by the production of a variety of antimicrobials and insecticides, and by triggering a hypersensitive defensive response of the plant, known as induced systemic resistance (ISR). Paenibacillus-derived antimicrobials also have applications in medicine, including polymyxins and fusaricidins, which are nonribosomal lipopeptides first isolated from strains of Paenibacillus polymyxa. Other useful molecules include exo-polysaccharides (EPS) and enzymes such as amylases, cellulases, hemicellulases, lipases, pectinases, oxygenases, dehydrogenases, lignin-modifying enzymes, and mutanases, which may have applications for detergents, food and feed, textiles, paper, biofuel, and healthcare. On the negative side, Paenibacillus larvae is the causative agent of American Foulbrood, a lethal disease of honeybees, while a variety of species are opportunistic infectors of humans, and others cause spoilage of pasteurized dairy products. This broad review summarizes the major positive and negative impacts of Paenibacillus: its realised and prospective contributions to agriculture, medicine, process manufacturing, and bioremediation, as well as its impacts due to pathogenicity and food spoilage. This review also includes detailed information in Additional files 1, 2, 3 for major known Paenibacillus species with their locations of isolation, genome sequencing projects, patents, and industrially significant compounds and enzymes. Paenibacillus will, over time, play increasingly important roles in sustainable agriculture and industrial biotechnology.

Indexed as

AnimalsGram-Positive Bacterial InfectionsHumansPaenibacillusAntimicrobialsBiocontrolBiofertilizerBiological nitrogen fixationBiomass degradationBiopesticideBioproductsPaenibacillusPGPRPlant growth promotion

Identifiers

PMID27905924
PMCPMC5134293
OpenAlexW2559480110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.